TITLE

AUSSIE DMT BAN

PUB. DATE
August 2012
SOURCE
American Herb Association Quarterly Newsletter;Summer2012, Vol. 27 Issue 3, pp14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that the Australian Therapeutic Goods Administration has withdrawn a potential ban in May 2012 on the use of entheogenic plants containing dimethyltryptamine (DMT) by religions and native people.
ACCESSION #
79564875

 

Related Articles

  • Australian TGA warns of exenatide-induced pancreatitis.  // Reactions Weekly;6/5/2010, Issue 1304, p2 

    The article deals with the public advisory issued by the Australian Therapeutic Goods Administration (TGA) in June 2010 regarding exenatide-induced pancreatitis.

  • TGA advises of dosing change for citalopram.  // Reactions Weekly;11/12/2011, Issue 1377, p3 

    The article reports on the recommendation by the Australian Therapeutic Goods Administration (TGA) that citalopram no longer be administered at dosages of less than 40 milligrams (mg)/day.

  • Australian TGA updates safety info for varenicline.  // Reactions Weekly;8/7/2010, Issue 1313, p6 

    The article reports on an update issued by the Australian Therapeutic Goods Administration (TGA) on the safety of varenicline (Champix), including its associated psychiatric side effects.

  • Combination antihypertensive approved.  // Australian Journal of Pharmacy;Apr2011, Vol. 92 Issue 1091, p52 

    The article offers information on the approval of the fixed-dose combination therapy, Twynsta, by the Therapeutic Goods Administration (TGA) in Australia.

  • Australia's TGA and NZ's Medsafe to merge.  // PharmacoEconomics & Outcomes News;6/25/2011, Issue 631, p9 

    The article discusses the merging of Australia's Therapeutic Goods Administration (TGA) and New Zealand's Medsafe into a joint scheme to be named the Australia New Zealand Therapeutic Products Agency (ANZTPA) to regulate therapeutic goods and provide health benefits for consumers, reduce...

  • IVD Australia sees new regs as more expensive than forecast.  // Medical Device Daily;3/31/2010, Vol. 14 Issue 61, p1 

    This article announces the plan of Australia's Therapeutic Goods Administration (TGA) to start transitioning its regulatory structure for in vitro diagnostics in July 2010.

  • TGA on board with single-audit program. McCARTY, MARK // Medical Device Daily;12/5/2012, Vol. 16 Issue 235, p6 

    The article reports on the participation of Australia's Therapeutic Goods Administration in the medical device single audit program MDSAP.

  • TGA approves PoC for AIDS virus. McCarty, Mark // Medical Device Daily;12/18/2012, Vol. 16 Issue 244, p6 

    The article reports that Determine HIV, a point-of-care test for the AIDS virus, has been approved by the Therapeutic Goods Administration (TGA) of Australia.

  • TGA: problems with meshes 'about the use.'.  // Medical Device Daily;10/30/2012, Vol. 16 Issue 210, p8 

    The article deals with the October 15, 2012 statement issued by Australia's Therapeutic Goods Administration about adverse events associated with surgical meshes.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics